Fig. 1: Primary endpoints.
No significant differences were observed between the 2GTKI subgroups regarding engraftment (a) or non-relapse mortality (NRM) (b).
Fig. 1: Primary endpoints. | Bone Marrow Transplantation
No significant differences were observed between the 2GTKI subgroups regarding engraftment (a) or non-relapse mortality (NRM) (b).
